Cantor Fitzgerald Starts Solta Medical (SLTM) at Buy; Slimming the Waistline, Fattening the Top Line

Article Stock Quotes (1) Comments (0)

Cantor Fitzgerald initiates coverage on Solta Medical (NASDAQ: SLTM) with a Buy. PT $4.00.

Analyst, Jeremy Feffer, said, "Aesthetic laser companies remain out of favor with investors despite the steady rebound in procedure volumes since the lows of late 2008/early 2009. Some companies are better positioned than others to differentiate themselves, and we believe that Solta falls into this category. The stock's multiple fails to account for the growth potential of the Liposonix opportunity and the strength of the base business, and we would be buyers at these levels."

For an analyst ratings summary and ratings history on Solta Medical click here. For more ratings news on Solta Medical click here.

Shares of Solta Medical closed at $3.02 yesterday, with a 52 week range of $1.15-$3.85.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
• William Blair Starts Teleflex (TFX) at Outperform
• Topeka Capital Starts Spansion (CODE) at Buy

Create E-mail Alert Related Categories

New Coverage

Related Entities

Cantor Fitzgerald

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?